Delivery Order SPE2DX22D0010-SPE2D824FPE38

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $6.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,959.19 firm fixed-price delivery order is for 4566295836 XTAMPZA ER 27 MG CAPSULE 100S, a specialty medication. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,837.82 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the supply of XTAMPZA ER 36 MG CAPSULE 100S, a type of medication. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,706.55 firm fixed-price delivery order is for the supply of XTAMPZA ER 27 MG capsules in 100-count bottles. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
The U.S. government awarded a $2,862.62 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the supply of XTAMPZA ER CAPS 36MG, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA, which serves as the primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,344.17, is for the delivery of XTAMPZA ER 36 MG CAPSULE 100S, a prescription medication. The contract is a delivery order with a firm fixed price and has an ultimate completion date of February 7, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp is the prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XTAMPZA ER CAPS 27MG, a prescription medication, with a ceiling value of $1,980.78 and a period of performance ending on April 21, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XTAMPZA ER 18 MG CAPSULE 100S, a pharmaceutical product, with a firm fixed price ceiling value of $1,663.38 and a performance period ending on May 19, 2025. The contract is not designated as a set-aside and is an open competition award. Amerisourcebergen Drug Corp is the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,368.43 firm fixed-price delivery order is for the supply of XTAMPZA ER 36 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, SPE2DX22D0010|SPE2D825FDW10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,251.21 firm fixed-price delivery order is for the supply of XTAMPZA ER CAPS 36MG, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XTAMPZA ER 9 MG CAPSULE 100S, a prescription medication. The contract has a ceiling value of $1,434.97 and is a Firm Fixed Price (FFP) type contract. The contract has an ultimate completion date of May 19, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D824FPE38
    Delivery Order

This is a $6,059.05 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of XTAMPZA ER CAPS 18MG, a prescription medication. The order has a completion date of July 18, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of pharmaceutical and medical supplies to military treatment facilities, veterans' hospitals, and other government healthcare providers. This award is not associated with a set-aside program.

Generated 10/16/24, 9:13 AM